Nightstar Therapeutics (NITE) Price Target & New Coverage by Chardan Capital
Chardan Capital analyst has started coverage on Nightstar Therapeutics (NITE) with a $40.0 TP and “Buy” rating. The TP means a potential upside of 82.23 % from company’s current stock price.
Despite the new coverage NITE is now trading 0.00% lower at $0.00 as of 12:04 AM New York time. Nightstar Therapeutics shares have [From2] 0% over the last 200 days, while the S&P 500 Index has increased 6.00% for the same time.
Nightstar Therapeutics (NITE) closed at $0 yesterday. A total of shares of the company’s stock traded hands. This is down from average of shares. Nightstar Therapeutics has a 52 week low of $0.00 and a 52 week high of $0. The company has a market cap of $ and a P/E ratio of 0.
Get the latest Nightstar Therapeutics (NITE) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Octafinance Looks at Why the Researchers at Chardan Capital has started Coverage on Nightstar Therapeutics (NITE) With “Buy” Rating and TP of $40.0 appeared first on Octafinance.